Clinical Trials Directory

Trials / Completed

CompletedNCT03546673

Health Benefits of Expressive Writing: Study One

Expressive Writing Among Chinese Breast Cancer Survivors: Study One

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
96 (actual)
Sponsor
University of Houston · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is a randomized controlled trial (RCT) with the aim of determining the cultural sensitivity, feasibility, and effectiveness of an expressive writing intervention for Chinese breast cancer survivors.

Detailed description

The study examines the potential health benefits (i.e., physical health, psychological health, and quality of life) of this expressive writing intervention for Chinese-speaking breast cancer survivors. The study also explores the mechanism through which expressive writing confers health benefits and investigates who will benefit most from the expressive writing intervention. Chinese-speaking breast cancer survivors who have completed primary treatment will be randomly assigned to a control writing condition, a self-regulation condition, or an emotional disclosure writing condition. Health outcomes are assessed at baseline, and 1, 3, and 6 months follow-ups. Mixed qualitative-quantitative mixed methods are used to explore the effect of the intervention on health outcomes and explore the mechanisms that explain the benefits of this intervention.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSelf-Regulation Condition
BEHAVIORALEmotional Disclosure Condition

Timeline

Start date
2009-07-01
Primary completion
2011-10-01
Completion
2011-10-01
First posted
2018-06-06
Last updated
2019-09-04

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03546673. Inclusion in this directory is not an endorsement.